Dynavax Technologies Corp. (DELISTED) (DVAX:DL)
15.50
0.00 (0.00%)
USD |
NASDAQ |
Feb 19, 16:00
Dynavax Technologies SG&A Expense (Quarterly) : 40.09M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.898B |
| Amicus Therapeutics, Inc. | 117.08M |
| Agios Pharmaceuticals, Inc. | 51.61M |
| Hyperion DeFi, Inc. | 2.594M |
| Edgewise Therapeutics, Inc. | 9.378M |